Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.51 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.51 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | BMP1 | P13497 | 1/20 | 0.44 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL619960 | 1.00 | CA2 (0.53) | CA2MAPK1CA1FOLH1NAALAD2 | |
| SCHEMBL1636628 | 1.00 | CA2 (0.53) | CA2MAPK1CA1FOLH1NAALAD2 | |
| SCHEMBL6413427 | 1.00 | CA2 (0.53) | CA2MAPK1CA1FOLH1NAALAD2 | |
| SCHEMBL936053 | 0.89 | NOD1 (0.54) | FOLH1NAALAD2RIMKLANOD1PLA2G2C | |
| SCHEMBL27625153 | 0.89 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL26352059 | 0.88 | FOLH1 (0.57) | CA2CA1FOLH1NAALAD2RIMKLA | |
| SCHEMBL9981032 | 0.88 | NOD1 (0.55) | FOLH1NAALAD2RIMKLANOD1 | |
| SCHEMBL29849120 | 0.85 | USP2 (0.50) | CA2MAPK1CA1BMP1PLA2G2C | |
| SCHEMBL16240658 | 0.84 | LMNA (0.56) | CA2CA1MEN1KMT2A | |
| SCHEMBL16240312 | 0.84 | TDP1 (0.47) | CA2MAPK1CA1BMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050208085-A1 | Gelling agent | AJINOMOTO CO. INC (JP) | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050208085-A1 | Gelling agent | ARGLU1, DGKA, GLRA1 | CA2 2229/4885MAPK1 1864/4885CA1 990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.